Navigation Links
Ontario minister seconds patient-pay plan for expensive cancer drugs

The idea of permitting hospitals to effect a charge on cancer patients for powerful, intravenous medications, not sponsored by the public health-care //system, is being seriously considered by Ontario's Health Minister.

George Smitherman said "There's no final decision yet. We've done some due diligence and obviously we're closer to having a policy. And in my heart, I believe it's the right thing said in a telephone interview yesterday. I have a responsibility to consider this once I have seen the final advice and to make sure that it's the right thing at the right time for Ontario."

The patients would be allowed to pay for those cancer drugs that have the approval of Health Canada but are frightfully expensive, which may be needed to extend the life of patients suffering from incurable cancers. The proposal will permit thousands of Ontario patients to buy the IV drugs at half the price in comparison to the United States Market.

According to Carolyn Henry, group leader of the London and District Myeloma Support Group, said "Imagine delaying treatment for lack of money, having to fundraise for treatment, putting your kids' postsecondary education at risk, potentially having to sell your house because you can't keep up the mortgage payments, which you incurred to pay for treatment, because you can't work.”

Bill Evans, an oncologist and president of the Juravinski Cancer Centre in Hamilton, stating that many new cancer drugs are awfully expensive said "People are going to seek these things out and they are willing to pay for them. What are you going to do -- say no, and inconvenience people? Or try to help with the safety and continuity of their care by making them available?"


'"/>




Page: 1

Related medicine news :

1. Nurses In Ontario demands Safe Disposable Needles
2. Ontario Institute for Cancer Research is funded $142 million
3. Students wants to extent Tution waiver in Ontario
4. Patients In Ontario Wait Longer For Treatment
5. Ontario Unprepared To Deal With Flu Pandemic
6. Ontario’s Entire Drug System Undergoes a Revam
7. Chemotherapy Queues in Ontario Stay Steady
8. Ontario Ranks Highest in Free Bird Flu Vaccination Rates
9. Ontario Medical Association Planning To Lure Back Expat Doctors
10. Ontario Addresses Shortage of Transplant Organs
11. Ontario Continues Support for Autistic Children
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/26/2016)... ... May 26, 2016 , ... Eating Recovery Center, Washington ... opening a brand new child and adolescent residential treatment center on June 1. ... even more specialized eating disorder treatment and access to life-saving care. , To ...
(Date:5/26/2016)... ... May 26, 2016 , ... American orthopedic surgeon ... officer of Blue Horizon International (BHI), Brian Mehling, M.D., spoke at an International ... May 5-6, 2016 in Chicago, IL, USA. Dr. Mehling’s presentation was focused on ...
(Date:5/26/2016)... ... , ... Bunion Bootie , the manufacturer of the newest and best ... by customer demand over the Mother’s Day Weekend promotion. So much so, that they ... has completely replenished its inventory levels, it hopes to continue its current sales pace, ...
(Date:5/26/2016)... ... May 26, 2016 , ... The introduction of our professional athletes ... YOUR HEAD ™”. , “We are proud to introduce Meghan Klingenberg, defender ... we have Brian Quick, wide receiver for Los Angeles who was a second round ...
(Date:5/26/2016)... , ... May 26, 2016 , ... May 2016 – ... so central to popular cosmetic improvement efforts. Record numbers of clients now ask about ... prominent or pouty, says Kally Papantoniou, MD, of Advanced Dermatology P.C. , ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... May 24, 2016   ... beide primären Endpunkte und demonstriert Ebenbürtigkeit ... ‚ausgezeichneter plus guter , ... ,      (Logo: http://photos.prnewswire.com/prnh/20130829/633895-a ... neue positive Daten von der MORA-Studie der Phase ...
(Date:5/24/2016)... 2016 Celsion Corporation (NASDAQ: ... provided an update on its ongoing OVATION study, ... GEN-1, the Company,s DNA-based immunotherapy, with the standard ... with advanced ovarian cancer who will undergo neoadjuvant ... an IL-12 DNA plasmid vector formulated as a ...
(Date:5/24/2016)... -- Open Access Journal Focusing on ... Elsevier , a world-leading provider of scientific, technical ... launch of Clinical Neurophysiology Practice ... clinical practice issues in clinical neurophysiology. The journal will ... and didactic reviews. It is an official journal of ...
Breaking Medicine Technology: